非酒精性脂肪性肝病患者脂肪与纤维化组织学评分与2型糖尿病发生的关联
瑞典1971至2009年活检确诊的396例基线无2型糖尿病的非酒精性脂肪性肝病患者回顾性研究,平均随访18.4年,132例(33%)发生2型糖尿病;纤维化3-4期患者发生比例51.2%高于0-2期的31.3%(P=.02),纤维化0-2期患者脂肪评分独立关联2型糖尿病发生(校正HR 1.34,95%CI 1.03-1.74,P=.03)。
要点
- 纤维化3-4期患者2型糖尿病发生比例51.2%,高于0-2期的31.3%(P=.02)。
- 纤维化0-2期患者脂肪评分独立关联2型糖尿病发生(校正HR 1.34,95%CI 1.03-1.74)。
- 纤维化3-4期患者中未发现与糖尿病发生相关的组织学因素。
核心结论
- 回顾性研究发现纤维化3-4期患者发生2型糖尿病的比例高于纤维化0-2期患者。
- 在纤维化0-2期患者中,脂肪评分与2型糖尿病发生风险相关。
研究设计与样本
- 回顾性研究纳入瑞典1971年至2009年经活检分析确诊的非酒精性脂肪性肝病患者396例,基线均无2型糖尿病。
- 按纤维化分期分为0-2期组(n=357)和3-4期组(n=39)。
- 2型糖尿病发生数据来自患者病历和国家登记。
- 采用多变量Cox回归模型分别计算组织学参数发生2型糖尿病的风险比,校正性别、年龄、体重指数和血清甘油三酯大于150 mg/dL。
主要发现
- 平均随访18.4年(范围0-41年),132例(33%)发生2型糖尿病。
- 纤维化3-4期患者发生2型糖尿病比例为51.2%,高于纤维化0-2期的31.3%(P=.02)。
- 纤维化0-2期患者中,脂肪评分独立关联2型糖尿病发生(校正风险比1.34;95%置信区间1.03-1.74;P=.03)。
- 纤维化3-4期患者中未发现与糖尿病发生相关的组织学因素。
- 非酒精性脂肪性肝炎的存在与2型糖尿病发生无关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is a strong risk factor for development of type 2 diabetes, but little is known about how long-term NAFLD or its histologic features affect risk. We aimed to investigate the cumulative incidence of type 2 diabetes in patients with NAFLD and to identify histologic factors that affect risk of diabetes. METHODS: We performed a retrospective study of 396 patients in Sweden diagnosed with NAFLD by biopsy analysis from 1971 through 2009 who did not have type 2 diabetes at baseline. Data on development of type 2 diabetes were collected from patient charts and national registers. Patients were categorized into groups with fibrosis stages 0-2 (n = 357) or stages 3-4 (n = 39). Hazard ratios of histologic parameters for type 2 diabetes development were calculated separately in a multivariate Cox regression model adjusted for sex, age, body mass index, and serum levels of triglycerides greater than 150 mg/dL. RESULTS: During a mean follow-up period of 18.4 years (range, 0-41 years), 132 individuals (33%) developed type 2 diabetes. A significantly higher proportion of patients with fibrosis stages 3-4 (51.2%) developed type 2 diabetes than patients with fibrosis stages 0-2 (31.3%) (P = .02). For patients with fibrosis stages 0-2, fat score associated independently with development of type 2 diabetes (adjusted hazard ratio, 1.34; 95% confidence interval, 1.03-1.74; P = .03). No histologic factors associated with development of diabetes in patients with fibrosis stages 3-4. Presence of nonalcoholic steatohepatitis was not associated with development of type 2 diabetes. CONCLUSIONS: In a retrospective study we found a higher proportion of patients with fibrosis stages 3-4 to develop type 2 diabetes than patients with fibrosis stages 0-2. In patients with fibrosis stages 0-2, fat score associates with risk of type 2 diabetes.
引用
- Björkström K, Stål P, Hultcrantz R, et al. Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2017. PMID: 28479500. doi:10.1016/j.cgh.2017.04.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。